GLP-1 agonists are a class of injectable medications that are used for type 2 diabetes and weight management
The Obesity Action Coalition is working to address these barriers and support people living with obesity
A separate 2024 meta-analysis (Alshammari et al.) confirmed the same conclusion, further strengthening the evidence base
These different mechanisms of action affect hunger and fat storage, making it crucial for providers to consider individual patient needs, including weight management, cardiovascular health, and overall metabolic control, when choosing between these treatments
If people are unable or unwilling to continue with drug treatment or maintain effective lifestyle changes, the initial health improvements will not be sustained, limiting long-term population-level benefit. Clinicians also need to be clear in communicating to patients that obesity is a chronic condition requiring long-term management
So, compounded Tirzepatide may still be available for a short time